Wakamoto Pharmaceutical Co.,Ltd. (TYO:4512)

Wakamoto Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Mar 31, 2012	Mar 31, 2011	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008
Cash & Equivalents	1,464	1,222	1,303	1,252	809.24
Short-Term Investments	405	405	645.04	1,211	2,956
Cash & Short-Term Investments	1,869	1,627	1,948	2,463	3,765
Cash Growth	14.87%	-16.50%	-20.90%	-34.58%	16.28%
Accounts Receivable	3,563	3,956	4,064	4,139	4,359
Other Receivables	2	3	10.38	78.09	-
Receivables	3,565	3,959	4,074	4,217	4,359
Inventory	2,314	2,209	1,676	1,787	1,549
Other Current Assets	150	153	108.55	111.78	105.46
Total Current Assets	8,305	8,234	8,098	8,876	10,010
Property, Plant & Equipment	5,002	5,720	6,508	5,551	3,539
Long-Term Investments	2,531	2,231	1,648	1,561	1,913
Other Intangible Assets	408	107	118.63	131.55	159.38
Long-Term Deferred Tax Assets	602	884	574.53	674.63	549.59
Other Long-Term Assets	1	-	757.85	951.41	947.08
Total Assets	16,849	17,176	17,705	17,745	17,118
Accounts Payable	1,221	1,659	1,360	1,640	1,469
Accrued Expenses	192	174	309.88	314.92	327
Short-Term Debt	323	241	224.87	29.06	-
Current Income Taxes Payable	30	52	20.17	130.6	86.61
Other Current Liabilities	167	187	245.83	1,186	528.32
Total Current Liabilities	1,933	2,313	2,161	3,300	2,411
Long-Term Debt	1,334	1,230	1,426	-	-
Other Long-Term Liabilities	5	7	5	138.1	272.34
Total Liabilities	4,747	5,012	5,031	4,982	4,247
Common Stock	3,395	3,395	3,396	3,396	3,396
Additional Paid-In Capital	2,675	2,675	2,676	2,676	2,676
Retained Earnings	5,902	6,124	6,708	6,831	6,652
Treasury Stock	-13	-10	-192.54	-174.87	-160.31
Comprehensive Income & Other	143	-20	86.82	34.9	307.07
Shareholders' Equity	12,102	12,164	12,674	12,763	12,871
Total Liabilities & Equity	16,849	17,176	17,705	17,745	17,118
Total Debt	1,657	1,471	1,651	29.06	-
Net Cash (Debt)	212	156	297.54	2,434	3,765
Net Cash Growth	35.90%	-47.57%	-87.78%	-35.35%	16.28%
Net Cash Per Share	6.09	4.51	8.65	70.66	111.06
Filing Date Shares Outstanding	34.79	34.81	34.38	34.43	34.47
Total Common Shares Outstanding	34.79	34.81	34.38	34.43	34.47
Working Capital	6,372	5,921	5,937	5,576	7,599
Book Value Per Share	347.83	349.47	368.67	370.70	373.38
Tangible Book Value	11,694	12,057	12,555	12,632	12,711
Tangible Book Value Per Share	336.11	346.40	365.22	366.88	368.75
Land	-	-	337.24	337.24	337.24
Construction In Progress	-	-	27.8	1,990	436

Source: S&P Global Market Intelligence. Standard template. Financial Sources.